It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESMC’s FA Score shows that 0 FA rating(s) are green whileMDRSF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESMC’s TA Score shows that 5 TA indicator(s) are bullish.
ESMC (@Medical/Nursing Services) experienced а +44.44% price change this week, while MDRSF (@Medical/Nursing Services) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.37%. For the same industry, the average monthly price growth was +2.04%, and the average quarterly price growth was +4.28%.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ESMC | MDRSF | ESMC / MDRSF | |
Capitalization | 2.89M | 1.22B | 0% |
EBITDA | 687K | 29.1M | 2% |
Gain YTD | 210.757 | 0.000 | - |
P/E Ratio | 7.80 | 196.01 | 4% |
Revenue | 12.9M | 220M | 6% |
Total Cash | 541K | 127M | 0% |
Total Debt | 516K | 121M | 0% |
ESMC | MDRSF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 16 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 60 | 41 | |
SMR RATING 1..100 | 36 | 90 | |
PRICE GROWTH RATING 1..100 | 35 | 72 | |
P/E GROWTH RATING 1..100 | 95 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ESMC's Valuation (83) in the Medical Specialties industry is in the same range as MDRSF (91) in the null industry. This means that ESMC’s stock grew similarly to MDRSF’s over the last 12 months.
MDRSF's Profit vs Risk Rating (41) in the null industry is in the same range as ESMC (60) in the Medical Specialties industry. This means that MDRSF’s stock grew similarly to ESMC’s over the last 12 months.
ESMC's SMR Rating (36) in the Medical Specialties industry is somewhat better than the same rating for MDRSF (90) in the null industry. This means that ESMC’s stock grew somewhat faster than MDRSF’s over the last 12 months.
ESMC's Price Growth Rating (35) in the Medical Specialties industry is somewhat better than the same rating for MDRSF (72) in the null industry. This means that ESMC’s stock grew somewhat faster than MDRSF’s over the last 12 months.
ESMC's P/E Growth Rating (95) in the Medical Specialties industry is in the same range as MDRSF (100) in the null industry. This means that ESMC’s stock grew similarly to MDRSF’s over the last 12 months.
ESMC | MDRSF | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 1 day ago90% | N/A |
Momentum ODDS (%) | 1 day ago81% | N/A |
MACD ODDS (%) | 1 day ago77% | N/A |
TrendWeek ODDS (%) | 1 day ago78% | 2 days ago5% |
TrendMonth ODDS (%) | 1 day ago76% | 2 days ago6% |
Advances ODDS (%) | 28 days ago78% | N/A |
Declines ODDS (%) | 26 days ago73% | N/A |
BollingerBands ODDS (%) | 1 day ago88% | N/A |
Aroon ODDS (%) | 1 day ago74% | N/A |
A.I.dvisor tells us that ESMC and MDRSF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESMC and MDRSF's prices will move in lockstep.
Ticker / NAME | Correlation To ESMC | 1D Price Change % | ||
---|---|---|---|---|
ESMC | 100% | N/A | ||
MDRSF - ESMC | 21% Poorly correlated | N/A | ||
MASI - ESMC | 9% Poorly correlated | +1.87% | ||
FONR - ESMC | 8% Poorly correlated | -0.59% | ||
MDT - ESMC | 8% Poorly correlated | -0.71% | ||
HBIO - ESMC | -1% Poorly correlated | +0.73% | ||
More |
A.I.dvisor tells us that MDRSF and NHNKF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRSF and NHNKF's prices will move in lockstep.
Ticker / NAME | Correlation To MDRSF | 1D Price Change % | ||
---|---|---|---|---|
MDRSF | 100% | N/A | ||
NHNKF - MDRSF | 28% Poorly correlated | N/A | ||
OSUR - MDRSF | 24% Poorly correlated | +0.36% | ||
MHUA - MDRSF | 21% Poorly correlated | -1.24% | ||
ESMC - MDRSF | 21% Poorly correlated | N/A | ||
NHNKY - MDRSF | 11% Poorly correlated | +3.54% | ||
More |